These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 3520657)

  • 1. Quantitative US attenuation in normal liver and in patients with diffuse liver disease: importance of fat.
    Taylor KJ; Riely CA; Hammers L; Flax S; Weltin G; Garcia-Tsao G; Conn HO; Kuc R; Barwick KW
    Radiology; 1986 Jul; 160(1):65-71. PubMed ID: 3520657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on frequency-dependent attenuation in the normal liver and spleen and in liver diseases, using the spectral-shift zero-crossing method.
    Itoh K; Yasuda Y; Suzuki O; Itoh H; Itoh T; Tsao JW; Konishi T; Koyano A
    J Clin Ultrasound; 1988 Oct; 16(8):553-62. PubMed ID: 3152399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attenuation of ultrasound in normal liver and diffuse liver disease in vivo.
    Maklad NF; Ophir J; Balsara V
    Ultrason Imaging; 1984 Apr; 6(2):117-25. PubMed ID: 6539974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In-vivo measurements of ultrasound attenuation in normal or diseased liver.
    Parker KJ; Asztely MS; Lerner RM; Schenk EA; Waag RC
    Ultrasound Med Biol; 1988; 14(2):127-36. PubMed ID: 3279691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The role of ultrasonography in the diagnosis of diffuse liver disease].
    Berrut C; Curati W; de Gautard R; Widmann JJ; Godin N; Loizeau E
    Schweiz Med Wochenschr; 1986 Feb; 116(7):215-8. PubMed ID: 3513304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computer-aided B-mode ultrasound diagnosis of hepatic steatosis: a feasibility study.
    Thijssen JM; Starke A; Weijers G; Haudum A; Herzog K; Wohlsein P; Rehage J; De Korte CL
    IEEE Trans Ultrason Ferroelectr Freq Control; 2008; 55(6):1343-54. PubMed ID: 18599422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is ultrasonography useful in the assessment of diffuse parenchymal liver disease?
    Sanford NL; Walsh P; Matis C; Baddeley H; Powell LW
    Gastroenterology; 1985 Jul; 89(1):186-91. PubMed ID: 3891495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relative attenuation measurements of ultrasound in the liver using the zerocrossing method.
    Fredfeldt KE
    Acta Radiol; 1989; 30(3):299-303. PubMed ID: 2660889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Ultrasound in the diagnostics of fatty liver in obesity].
    Szebeni A; Tolvaj G; Stotz G
    Orv Hetil; 2010 Apr; 151(14):572-5. PubMed ID: 20332074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo acoustic attenuation in liver: correlations with blood tests and histology.
    Duerinckx A; Rosenberg K; Hoefs J; Aufrichtig D; Cole-Beuglet C; Kanel G; Lottenberg S; Ferrari LA
    Ultrasound Med Biol; 1988; 14(5):405-13. PubMed ID: 3051614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histologic abnormalities are common in protocol liver allograft biopsies from patients with normal liver function tests.
    Abraham SC; Poterucha JJ; Rosen CB; Demetris AJ; Krasinskas AM
    Am J Surg Pathol; 2008 Jul; 32(7):965-73. PubMed ID: 18460980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Focal and diffuse liver disease studied by quantitative microstructural sonography.
    King DL; Lizzi FL; Feleppa EJ; Wai PM; Yaremko MM; Rorke MC; Herbst J
    Radiology; 1985 May; 155(2):457-62. PubMed ID: 2984720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fatty liver. Chemical shift phase-difference and suppression magnetic resonance imaging techniques in animals, phantoms, and humans.
    Mitchell DG; Kim I; Chang TS; Vinitski S; Consigny PM; Saponaro SA; Ehrlich SM; Rifkin MD; Rubin R
    Invest Radiol; 1991 Dec; 26(12):1041-52. PubMed ID: 1765436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver steatosis quantification using magnetic resonance imaging: a prospective comparative study with liver biopsy.
    Mennesson N; Dumortier J; Hervieu V; Milot L; Guillaud O; Scoazec JY; Pilleul F
    J Comput Assist Tomogr; 2009; 33(5):672-7. PubMed ID: 19820490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of ultrasonic attenuation in diffuse diseases of spleen and liver.
    Wilson LS; Robinson DE; Griffiths KA; Manoharan A; Doust BD
    Ultrason Imaging; 1987 Oct; 9(4):236-47. PubMed ID: 3330337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accuracy of ultrasonography in diagnosis of hepatocellular disease.
    Gosink BB; Lemon SK; Scheible W; Leopold GR
    AJR Am J Roentgenol; 1979 Jul; 133(1):19-23. PubMed ID: 110064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is hepatic ultrasonography a valid alternative tool to liver biopsy? Report on 507 cases studied with both techniques.
    Celle G; Savarino V; Picciotto A; Magnolia MR; Scalabrini P; Dodero M
    Dig Dis Sci; 1988 Apr; 33(4):467-71. PubMed ID: 3280274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative estimation of liver attenuation and echogenicity: normal state versus diffuse liver disease.
    Garra BS; Insana MF; Shawker TH; Russell MA
    Radiology; 1987 Jan; 162(1 Pt 1):61-7. PubMed ID: 3538154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Value of ultrasonography in the diagnosis of cirrhoses. Prospective study of 128 patients].
    Richard P; Bonniaud P; Barthélémy C; Etaix JP; Veyret C; Audigier JC; Fraisse H
    J Radiol; 1985; 66(8-9):503-6. PubMed ID: 3912496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative estimation of attenuation in ultrasound video images: correlation with histology in diffuse liver disease.
    Graif M; Yanuka M; Baraz M; Blank A; Moshkovitz M; Kessler A; Gilat T; Weiss J; Walach E; Amazeen P; Irving CS
    Invest Radiol; 2000 May; 35(5):319-24. PubMed ID: 10803673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.